Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher M Booth

Showing results (331-340 of 349) with videos related to

Pageof 35
Sort By:
Journal of Global Oncology|August 8, 2018
Delivery of Pediatric Cancer Care in Mexico: A National SurveyLaura Rodriguez-Romo, Alberto Olaya Vargas, Sumit Gupta, et al.
Oncotarget|March 1, 2018
A randomized phase II study of pelareorep and docetaxel or docetaxel alone in men with metastatic castration resistant prostate cancer: CCTG study IND 209Bernhard Josef Eigl, Kim Chi, Dongsheng Tu, et al.
Nature Reviews. Clinical Oncology|October 1, 2024
Two decades of advances in clinical oncology - lessons learned and future directionsSusana Banerjee, Christopher M Booth, Eduardo Bruera, et al.
The Lancet. Oncology|January 20, 2025
Global linear accelerator requirements and personalised country recommendations: a cross-sectional, population-based studyFabio Y Moraes, Andre G Gouveia, Vanessa Freitas Bratti, et al.
Journal of Cancer Policy|November 29, 2023
Challenges in building radiotherapy capacity: A longitudinal study evaluating eight years of the Brazilian radiotherapy expansion planAndre G Gouveia, Gustavo A Viani, Vanessa F Bratti, et al.
The Lancet. Oncology|September 4, 2025
Importance of responder criteria for reporting health-related quality-of-life data in clinical trials for advanced cancer: recommendations of Common Sense Oncology and the European Organisation for Research and Treatment of CancerIan F Tannock, Madeline Lee Pe, Christopher M Booth, et al.
The Lancet. Oncology|February 6, 2025
Common Sense Oncology principles for the design, analysis, and reporting of phase 3 randomised clinical trialsBishal Gyawali, Elizabeth A Eisenhauer, Winette van der Graaf, et al.
Journal of the National Cancer Institute|January 29, 2026
Effects of a structured exercise program on motivational outcomes in patients with Colon cancerKerry S Courneya, Christopher M Booth, Janette L Vardy, et al.
JAMA Oncology|September 17, 2020
Efficacy and Safety of nab-Paclitaxel vs Paclitaxel on Survival in Patients With Platinum-Refractory Metastatic Urothelial Cancer: The Canadian Cancer Trials Group BL.12 Randomized Clinical TrialSrikala S Sridhar, Normand Blais, Ben Tran, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 20, 2016
Effects of a Structured Exercise Program on Physical Activity and Fitness in Colon Cancer Survivors: One Year Feasibility Results from the CHALLENGE TrialKerry S Courneya, Janette L Vardy, Christopher J O'Callaghan, et al.
Pageof 35

Showing results (331-340 of 349) with videos related to

Sort By:
Pageof 35
Journal of Global Oncology|August 8, 2018
Delivery of Pediatric Cancer Care in Mexico: A National SurveyLaura Rodriguez-Romo, Alberto Olaya Vargas, Sumit Gupta, et al.
Oncotarget|March 1, 2018
A randomized phase II study of pelareorep and docetaxel or docetaxel alone in men with metastatic castration resistant prostate cancer: CCTG study IND 209Bernhard Josef Eigl, Kim Chi, Dongsheng Tu, et al.
Nature Reviews. Clinical Oncology|October 1, 2024
Two decades of advances in clinical oncology - lessons learned and future directionsSusana Banerjee, Christopher M Booth, Eduardo Bruera, et al.
The Lancet. Oncology|January 20, 2025
Global linear accelerator requirements and personalised country recommendations: a cross-sectional, population-based studyFabio Y Moraes, Andre G Gouveia, Vanessa Freitas Bratti, et al.
Journal of Cancer Policy|November 29, 2023
Challenges in building radiotherapy capacity: A longitudinal study evaluating eight years of the Brazilian radiotherapy expansion planAndre G Gouveia, Gustavo A Viani, Vanessa F Bratti, et al.
The Lancet. Oncology|September 4, 2025
Importance of responder criteria for reporting health-related quality-of-life data in clinical trials for advanced cancer: recommendations of Common Sense Oncology and the European Organisation for Research and Treatment of CancerIan F Tannock, Madeline Lee Pe, Christopher M Booth, et al.
The Lancet. Oncology|February 6, 2025
Common Sense Oncology principles for the design, analysis, and reporting of phase 3 randomised clinical trialsBishal Gyawali, Elizabeth A Eisenhauer, Winette van der Graaf, et al.
Journal of the National Cancer Institute|January 29, 2026
Effects of a structured exercise program on motivational outcomes in patients with Colon cancerKerry S Courneya, Christopher M Booth, Janette L Vardy, et al.
JAMA Oncology|September 17, 2020
Efficacy and Safety of nab-Paclitaxel vs Paclitaxel on Survival in Patients With Platinum-Refractory Metastatic Urothelial Cancer: The Canadian Cancer Trials Group BL.12 Randomized Clinical TrialSrikala S Sridhar, Normand Blais, Ben Tran, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 20, 2016
Effects of a Structured Exercise Program on Physical Activity and Fitness in Colon Cancer Survivors: One Year Feasibility Results from the CHALLENGE TrialKerry S Courneya, Janette L Vardy, Christopher J O'Callaghan, et al.
Pageof 35